Literature DB >> 12934052

Prevalence of erectile dysfunction and associated factors among men without concomitant diseases: a population study.

A Nicolosi1, D B Glasser, E D Moreira, M Villa.   

Abstract

We interviewed a population sample of 2412 men aged 40-70 y in Brazil, Italy, Japan and Malaysia about medical history, lifestyle habits and sexual behavior. Men were classified as having moderate or complete erectile dysfunction (ED) if they reported to be sometimes or never able to achieve and maintain an erection satisfactory for sexual intercourse, respectively. There were 1335 men with no diagnosis of cardiovascular or prostate diseases, diabetes, ulcer or depression, nor taking hormones. The prevalence of ED was 16.1%. ED was associated with age (the risk increased 8% per y), moderate (odds ratio (OR)=2.2) or severe (OR=4.9) lower urinary tract symptoms and smoking (OR=2.3 for >30 cigarettes/day). It was inversely associated with physical activity (OR=0.5) and higher educational levels. Between the ages of 40 and 70 y, almost one in six 'healthy' men is affected by ED. Further research should look at preclinical disease stages and genetic factors.

Entities:  

Mesh:

Year:  2003        PMID: 12934052     DOI: 10.1038/sj.ijir.3901010

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  20 in total

1.  Sexual quality of life is impaired in patients with chronic hepatitis C.

Authors:  J Vergniol; S Duc; G Hou; J B Hiriart; J Foucher; F Chenus; C Fabères; F Chermak; A Lafournière; N Souakri; V de Lédinghen
Journal:  Int J Impot Res       Date:  2016-02-11       Impact factor: 2.896

2.  Association between smoking, passive smoking, and erectile dysfunction: results from the Boston Area Community Health (BACH) Survey.

Authors:  Varant Kupelian; Carol L Link; John B McKinlay
Journal:  Eur Urol       Date:  2007-03-16       Impact factor: 20.096

Review 3.  What do most erectile dysfunction guidelines have in common? No evidence-based discussion or recommendation of heart-healthy lifestyle changes and/or Panax ginseng.

Authors:  Mark A Moyad; Kwangsung Park
Journal:  Asian J Androl       Date:  2012-09-24       Impact factor: 3.285

4.  Impact of frequency of intercourse on erectile dysfunction: a cross-sectional study in Wuhan, China.

Authors:  Zhanting Qin; Binqun Tian; Xinghuan Wang; Tongzu Liu; Jinbing Bai
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-06-09

5.  Beyond the lower urinary tract: the association of urologic and sexual symptoms with common illnesses.

Authors:  Mary P Fitzgerald; Carol L Link; Heather J Litman; Thomas G Travison; John B McKinlay
Journal:  Eur Urol       Date:  2007-03-19       Impact factor: 20.096

6.  The effect of eurycoma longifolia Jack on spermatogenesis in estrogen-treated rats.

Authors:  Norhazlina Abdul Wahab; Norfilza M Mokhtar; Wan Nurul Heriza A Halim; Srijit Das
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

7.  Predicting erectile dysfunction in sexually active patients seeking prostate health screening: proposal for a multivariable risk stratification.

Authors:  V Favilla; G I Russo; G Reale; S Leone; T Castelli; S La Vignera; R A Condorelli; A E Calogero; S Cimino; G Morgia
Journal:  Int J Impot Res       Date:  2015-07-30       Impact factor: 2.896

Review 8.  A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunction.

Authors:  Konstantinos Hatzimouratidis
Journal:  Ther Adv Urol       Date:  2014-08

9.  Low-fat diet and exercise preserve eNOS regulation and endothelial function in the penis of early atherosclerotic pigs: a molecular analysis.

Authors:  Biljana Musicki; Tongyun Liu; Travis Strong; Liming Jin; M Harold Laughlin; James R Turk; Arthur L Burnett
Journal:  J Sex Med       Date:  2008-01-10       Impact factor: 3.802

Review 10.  Treatment of benign prostatic hyperplasia in hypertensive men.

Authors:  William B White; Timothy Moon
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-04       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.